[	O
Treatment	O
of	O
the	O
diabetic	O
foot	B-Organism_subdivision
by	O
hyperbaric	O
oxygen	O
]	O

Diabetic	O
foot	B-Pathological_formation
wounds	I-Pathological_formation
are	O
consequences	O
of	O
the	O
neuropathy	O
and	O
the	O
small	O
and	O
large	O
vessel	B-Multi-tissue_structure
disease	O
that	O
complicate	O
diabetes	O
.	O

At	O
the	O
cellular	B-Cell
level	O
,	O
the	O
result	O
is	O
hypoxia	O
which	O
impairs	O
wound	B-Pathological_formation
healing	O
.	O

Hyperbaric	O
oxygenation	O
(	O
HBO	O
)	O
may	O
be	O
a	O
useful	O
adjuvant	O
to	O
wound	B-Pathological_formation
care	O
.	O

It	O
leads	O
to	O
enhanced	O
oxygenation	O
of	O
the	O
affected	O
tissues	B-Tissue
,	O
has	O
an	O
antiseptic	O
effect	O
,	O
reduces	O
edema	B-Pathological_formation
,	O
and	O
accelerates	O
collagen	O
production	O
and	O
angiogenesis	O
,	O
thus	O
enhancing	O
tissue	B-Tissue
repair	O
.	O

14	O
diabetics	O
with	O
chronic	B-Pathological_formation
nonhealing	I-Pathological_formation
wounds	I-Pathological_formation
which	O
did	O
not	O
respond	O
to	O
treatment	O
for	O
at	O
least	O
3	O
months	O
were	O
treated	O
by	O
HBO	O
.	O

All	O
had	O
palpable	O
pedal	O
pulses	O
.	O

Transcutaneous	B-Immaterial_anatomical_entity
measurements	O
of	O
tissue	B-Tissue
pO2	O
showed	O
elevation	O
from	O
20	O
+	O
/	O
-	O
10	O
mm	O
Hg	O
during	O
air	O
breathing	O
to	O
643	O
+	O
/	O
-	O
242	O
mm	O
Hg	O
while	O
breathing	O
pure	O
oxygen	O
at	O
2	O
.	O
5	O
ATA	O
.	O

They	O
were	O
treated	O
with	O
HBO	O
in	O
56	O
+	O
/	O
-	O
10	O
consecutive	O
HBO	O
sessions	O
.	O

In	O
11	O
there	O
was	O
complete	O
wound	B-Pathological_formation
healing	O
,	O
while	O
in	O
1	O
there	O
was	O
partial	O
response	O
,	O
in	O
1	O
minimal	O
response	O
,	O
and	O
in	O
1	O
a	O
transient	O
response	O
.	O

HBO	O
is	O
useful	O
in	O
chronic	B-Pathological_formation
nonhealing	I-Pathological_formation
wounds	I-Pathological_formation
of	O
the	O
diabetic	O
foot	B-Organism_subdivision
and	O
of	O
the	O
diabetic	O
foot	B-Organism_subdivision
with	O
impending	O
amputation	O
.	O

It	O
is	O
a	O
safe	O
mode	O
of	O
therapy	O
,	O
but	O
further	O
studies	O
are	O
required	O
to	O
establish	O
its	O
efficacy	O
and	O
to	O
ascertain	O
which	O
diabetic	O
patients	O
and	O
wounds	B-Pathological_formation
will	O
benefit	O
the	O
most	O
from	O
it	O
.	O

